Annual Current Liabilities
$14.82 M
+$7.28 M+96.59%
December 31, 2024
Summary
- As of March 10, 2025, VYNE annual total current liabilities is $14.82 million, with the most recent change of +$7.28 million (+96.59%) on December 31, 2024.
- During the last 3 years, VYNE annual current liabilities has fallen by -$3.59 million (-19.51%).
- VYNE annual current liabilities is now -31.91% below its all-time high of $21.77 million, reached on December 31, 2020.
Performance
VYNE Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$14.82 M
+$2.16 M+17.04%
December 1, 2024
Summary
- As of March 10, 2025, VYNE quarterly total current liabilities is $14.82 million, with the most recent change of +$2.16 million (+17.04%) on December 1, 2024.
- Over the past year, VYNE quarterly current liabilities has stayed the same.
- VYNE quarterly current liabilities is now -74.28% below its all-time high of $57.62 million, reached on June 30, 2021.
Performance
VYNE Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
VYNE Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.6% | 0.0% |
| 3 y3 years | -19.5% | 0.0% |
| 5 y5 years | +39.0% | 0.0% |
VYNE Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.5% | +96.6% | -19.5% | +132.5% |
| 5 y | 5-year | -31.9% | +96.6% | -74.3% | +132.5% |
| alltime | all time | -31.9% | +1824.5% | -74.3% | +279.7% |
VYNE Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $14.82 M(+96.6%) | - |
| Dec 2024 | - | $14.82 M(+17.0%) |
| Sep 2024 | - | $12.66 M(+7.7%) |
| Jun 2024 | - | $11.75 M(+69.6%) |
| Mar 2024 | - | $6.93 M(-8.1%) |
| Dec 2023 | $7.54 M(-19.3%) | $7.54 M(+16.9%) |
| Sep 2023 | - | $6.45 M(+1.2%) |
| Jun 2023 | - | $6.37 M(-15.2%) |
| Mar 2023 | - | $7.52 M(-19.5%) |
| Dec 2022 | $9.35 M(-49.2%) | $9.35 M(+36.6%) |
| Sep 2022 | - | $6.84 M(+0.1%) |
| Jun 2022 | - | $6.83 M(-20.4%) |
| Mar 2022 | - | $8.59 M(-53.4%) |
| Dec 2021 | $18.41 M | $18.41 M(-12.3%) |
| Sep 2021 | - | $21.00 M(-63.6%) |
| Jun 2021 | - | $57.62 M(+167.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $21.55 M(-1.0%) |
| Dec 2020 | $21.77 M(+104.2%) | $21.77 M(-6.2%) |
| Sep 2020 | - | $23.19 M(-4.3%) |
| Jun 2020 | - | $24.23 M(-57.2%) |
| Mar 2020 | - | $56.59 M(+430.8%) |
| Dec 2019 | $10.66 M(+11.7%) | $10.66 M(+12.8%) |
| Sep 2019 | - | $9.45 M(-20.6%) |
| Jun 2019 | - | $11.91 M(+12.0%) |
| Mar 2019 | - | $10.63 M(+11.3%) |
| Dec 2018 | $9.54 M(+22.1%) | $9.54 M(+18.4%) |
| Sep 2018 | - | $8.06 M(-6.8%) |
| Jun 2018 | - | $8.65 M(+2.1%) |
| Mar 2018 | - | $8.47 M(+8.4%) |
| Dec 2017 | $7.82 M(+100.3%) | $7.82 M(+8.2%) |
| Sep 2017 | - | $7.22 M(+85.0%) |
| Dec 2016 | $3.90 M(+406.9%) | $3.90 M |
| Dec 2015 | $770.00 K | - |
FAQ
- What is VYNE Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for VYNE Therapeutics?
- What is VYNE Therapeutics annual current liabilities year-on-year change?
- What is VYNE Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly current liabilities year-on-year change?
What is VYNE Therapeutics annual total current liabilities?
The current annual current liabilities of VYNE is $14.82 M
What is the all time high annual current liabilities for VYNE Therapeutics?
VYNE Therapeutics all-time high annual total current liabilities is $21.77 M
What is VYNE Therapeutics annual current liabilities year-on-year change?
Over the past year, VYNE annual total current liabilities has changed by +$7.28 M (+96.59%)
What is VYNE Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of VYNE is $14.82 M
What is the all time high quarterly current liabilities for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly total current liabilities is $57.62 M
What is VYNE Therapeutics quarterly current liabilities year-on-year change?
Over the past year, VYNE quarterly total current liabilities has changed by $0.00 (0.00%)